- Genetron Health, a Beijing-North Caroline diagnostic company, announced a city-wide early screening test for liver cancer in Wuxi city using the company's blood-based HCCscreen.
- Sinopharm has filed for China approval of at least one of its two COVID-19 inactivated vaccines based on initial data from a global Phase III trial, according to a Bloomberg report.
- Eluminex Biosciences, a Suzhou ophthalmic biotech startup, closed a $50 million Series A Financing from Lilly Asia Ventures, Hillhouse's GL Ventures and Quan Capital.
For further details see:
Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs